05/22/2024 6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024 6:54 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 3:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 7:51 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 3:04 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 8:27 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 3:02 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/24/2024 7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024 7:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:51 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 6:08 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 6:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:54 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:52 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024 6:04 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 7:59 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:38 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:40 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 4:24 PM | Viking Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/07/2024 4:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2024 7:39 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:32 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 8:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:23 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 12:24 PM | STATE STREET CORP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024 7:35 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:36 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:26 PM | MILLENNIUM MANAGEMENT LLC (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024 8:35 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:36 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:37 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:22 PM | FOEHR MATTHEW W (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:24 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:25 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:27 PM | Rowland Charles A Jr (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
🚀 Tap into this explosive trade opportunity asap (Ad) I learned about these explosive stocks during my two decades on Wall Street…
And used them to help grow my old hedge fund from just a few million to over $700 million dollars*.
So it’s safe to say… these bad boys work.
What’s the secret behind these special trades?
Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”… Go here to see how you can exploit my next “Calendar Stock”. |
01/04/2024 8:28 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 7:12 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:30 PM | VIKING GLOBAL INVESTORS LP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G | |
10/25/2023 4:05 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 3:24 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 3:23 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |